ROQ.L

Roquefort Therapeutics plc [ROQ.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ROQ.L Stock Summary

In the News

ROQ.L Financial details

Company Rating
-
Market Cap
8.72M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
05 Jun 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
4.6
Current Ratio
15.75
Debt / Equity
0.41
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-85.71%
SMA50
-87.5%
SMA100
-85.71%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
129.15M
Shs Float
35.8M
-
-
-
-
Target Price
-
52W Range
0.0-11.75
52W High
-
52W Low
-
RSI
3
Rel Volume
-
Avg Volume
144.09K
Volume
Perf Week
9900%
Perf Month
-3.57%
Perf Quarter
-
Perf Half Y
-8.47%
-
-
-
-
Beta
-0.036246
-
-
Volatility
2.34%, 3.4%
Prev Close
9900%
Price
6.75
Change
9900%

ROQ.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2021-12-31
Revenue per share
0
Net income per share
0
Operating cash flow per share
0
Free cash flow per share
0
Cash per share
0
Book value per share
0
Tangible book value per share
0
Share holders equity per share
0
Interest debt per share
0
Market cap
0
Enterprise value
-899.72K
P/E ratio
0
Price to sales ratio
0
POCF ratio
0
PFCF ratio
0
P/B Ratio
0
PTB ratio
0
EV to sales
0
Enterprise value over EBITDA
0
EV to operating cash flow
0
EV to free cash flow
0
Earnings yield
0
Free cash flow yield
0
Debt to equity
0.12
Debt to assets
0.1
Net debt to EBITDA
0
Current ratio
15.75
Interest coverage
0
Income quality
0
Dividend Yield
0
Payout ratio
0
Sales general and administrative to revenue
0
Research and developement to revenue
0
Intangibles to total assets
0.32
Capex to operating cash flow
0
Capex to revenue
0
Capex to depreciation
0
Stock based compensation to revenue
0
Graham number
0
ROIC
0
Return on tangible assets
0
Graham Net
0
Working capital
2.88M
Tangible asset value
2.6M
Net current asset value
2.6M
Invested capital
0
Average receivables
0
Average payables
0
Average inventory
0
Days sales outstanding
0
Days payables outstanding
0
Days of inventory on hand
0
Receivables turnover
0
Payables turnover
0
Inventory turnover
0
ROE
0
Capex per share
0

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2020-09-302021-06-302021-12-31 2022-06-30
Revenue per share
0000
Net income per share
0000
Operating cash flow per share
0000
Free cash flow per share
0000
Cash per share
0000
Book value per share
0000
Tangible book value per share
0000
Share holders equity per share
0000
Interest debt per share
0000
Market cap
2.19M000
Enterprise value
2.07M-880.45K-899.72K-3.33M
P/E ratio
-72.24000
Price to sales ratio
0000
POCF ratio
-242.97000
PFCF ratio
-242.97000
P/B Ratio
18.78000
PTB ratio
18.78000
EV to sales
0000
Enterprise value over EBITDA
-273.75000
EV to operating cash flow
-230.2000
EV to free cash flow
-230.2000
Earnings yield
0000
Free cash flow yield
0000
Debt to equity
00.020.120.41
Debt to assets
00.020.10.29
Net debt to EBITDA
15.19000
Current ratio
062.3615.753.13
Interest coverage
0000
Income quality
1.19000
Dividend Yield
0000
Payout ratio
0000
Sales general and administrative to revenue
0000
Research and developement to revenue
0000
Intangibles to total assets
0000.28
Capex to operating cash flow
0000
Capex to revenue
0000
Capex to depreciation
0000
Stock based compensation to revenue
0000
Graham number
0000
ROIC
0.07000
Return on tangible assets
-0.07000
Graham Net
0000
Working capital
116.43K879.36K2.88M2.33M
Tangible asset value
116.43K879.36K4.08M2.05M
Net current asset value
116.43K879.36K2.6M2.05M
Invested capital
0000
Average receivables
0000
Average payables
0000
Average inventory
0000
Days sales outstanding
0000
Days payables outstanding
0000
Days of inventory on hand
0000
Receivables turnover
0000
Payables turnover
0000
Inventory turnover
0000
ROE
-0.07000
Capex per share
0000

ROQ.L Frequently Asked Questions

What is Roquefort Therapeutics plc stock symbol ?

Roquefort Therapeutics plc is a GB stock and trading under the symbol ROQ.L

What is Roquefort Therapeutics plc stock quote today ?

Roquefort Therapeutics plc stock price is $6.75 today.

Is Roquefort Therapeutics plc stock public?

Yes, Roquefort Therapeutics plc is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap